ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Mercaptyl®:Abbott AG
Information professionnelle complèteDDDimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
TitulaireMise à jour 
M01CC01 - PenicillamineATC-DDD Version 2016. Source: WHO
M - Musculo-Skeletal System
 
M01 - Antiinflammatory and Antirheumatic Products

Corticosteroids, see H02 - Corticosteroids for systemic use.

M01C - Specific Antirheumatic Agents

This group comprises specific antirheumatic preparations.
Penicillamine, which is also used in conditions associated with impaired copper metabolism and as an antidot in copper poisoning, is classified in this group regardless of indication.
Other Disease Modifying Antirheumatic Drugs (DMARDs) see:
A07EC - Aminosalicylic acid and similar agents
L01BA - Folic acid analogues
L04AA - Selective immunosuppressants
L04AX - Other immunosuppressants
P01BA - Aminoquinolines

The DDDs are based on the treatment of rheumatoid arthritis.

M01CC - Penicillamine and Similar Agents
 
M01CC01 - Penicillamine
Concentr.Adm.RouteNote
 O 
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home